Jazz Pharmaceuticals (JAZZ) grants director 1,605 restricted stock units
Rhea-AI Filing Summary
Smith Mark Douglas reported acquisition or exercise transactions in this Form 4 filing.
Jazz Pharmaceuticals director Mark Douglas Smith reported an equity compensation grant of 1,605 restricted stock units, each representing a right to receive one ordinary share. The award was made at $0.0000 per share under the 2007 Amended and Restated Non-Employee Directors Stock Award Plan and will vest in full on July 23, 2027, subject to continuous service and other conditions. Following this grant, Smith directly holds 11,285 ordinary shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 1,605 shares
Net Buy
1 txn
Insider
Smith Mark Douglas
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Ordinary Shares F1 | 1,605 | $0.00 | $0.00 |
Holdings After Transaction:
Ordinary Shares — 11,285 shares (Direct)
Footnotes (1)
- F1. These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027.
Key Figures
Restricted stock units granted: 1605.0000 shares
Price per unit: 0.0000
Shares held after transaction: 11285.0000 shares
+2 more
5 metrics
Restricted stock units granted
1605.0000 shares
Equity award to director Mark Douglas Smith on 2026-08-05
Price per unit
0.0000
Reported grant price per restricted stock unit
Shares held after transaction
11285.0000 shares
Total ordinary shares directly held by Smith following the award
Vesting date
July 23, 2027
Restricted stock units vest in full on this date, subject to conditions
Acquisition transactions in filing
1
Number of acquisition-type transactions reported in this Form 4
Key Terms
restricted stock units, contingent right, continuous service, Non-Employee Directors Stock Award Plan
4 terms
restricted stock units financial
"These restricted stock units are granted pursuant to the Issuer's 2007 Amended"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
contingent right financial
"Each restricted stock unit represents a contingent right to receive one ordinary"
continuous service financial
"Subject to the Reporting Person's continuous service and certain additional"
Non-Employee Directors Stock Award Plan financial
"Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Jazz Pharmaceuticals (JAZZ) director Mark Douglas Smith report in this Form 4?
Mark Douglas Smith reported receiving an equity grant of 1,605 restricted stock units linked to Jazz Pharmaceuticals ordinary shares. The grant vests fully on July 23, 2027, subject to continuous service, and brings his direct holdings to 11,285 ordinary shares after the award.
How many units did Mark Douglas Smith effectively acquire in the JAZZ transaction and at what price?
Smith was granted 1,605 restricted stock units, each representing a right to receive one ordinary share, at a reported price of $0.0000 per unit. This reflects a compensation award rather than an open-market purchase, increasing his reported direct stake in Jazz Pharmaceuticals.
When do the restricted stock units reported by Jazz Pharmaceuticals (JAZZ) vest?
The reported 1,605 restricted stock units are scheduled to vest in full on July 23, 2027. Vesting is contingent on the reporting person’s continuous service with Jazz Pharmaceuticals and satisfaction of certain additional conditions described in the equity award’s terms.
Under which plan were the JAZZ restricted stock units granted to Mark Douglas Smith?
The 1,605 restricted stock units were granted under Jazz Pharmaceuticals’ 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each unit represents a contingent right to receive one ordinary share upon vesting, aligning director compensation with the company’s equity performance over time.
Was the JAZZ Form 4 transaction made under a Rule 10b5-1 trading plan?
The filing indicates the transaction was not made under a Rule 10b5-1 trading plan, as the related checkbox was not affirmed. The reported activity is an equity compensation grant of restricted stock units rather than a discretionary market trade under a preset trading arrangement.